<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Microvolt T-wave alternans (TWA) predicts arrhythmic risk in patients with <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>While TWA has widely been assessed by the spectral method, it has been poorly characterized in healthy people as well as in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> patients by the modified moving average (<z:chebi fb="0" ids="34840">MMA</z:chebi>) method </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We enrolled 729 consecutive subjects, referred for exercise stress test (EST) </plain></SENT>
<SENT sid="3" pm="."><plain>T-wave alternans was assessed by the <z:chebi fb="0" ids="34840">MMA</z:chebi> method, considering <z:hpo ids='HP_0000001'>all</z:hpo> 12 electrocardiogram (ECG) leads (TWA_tot) or the 6 ECG pre-cordial leads only (TWA_prec) </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were divided into five groups: (i) no history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> EST (Group 1); (ii) no history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> but positive EST (Group 2); (iii) <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> without any <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> (Group 3)]; (iv) old <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> (Group 4); (v) recent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> (Group 5) </plain></SENT>
<SENT sid="5" pm="."><plain>T-wave alternans values &gt;95th percentile of those measured in Group 1 were considered 'abnormal' </plain></SENT>
<SENT sid="6" pm="."><plain>The 95th percentile of TWA values in Group 1 was 75 µV for TWA_tot and 65 µV for TWA_prec </plain></SENT>
<SENT sid="7" pm="."><plain>T-wave alternans values and prevalence of abnormal TWA increased from Groups 1-2 to Group 5 (P&lt; 0.00001 for both) </plain></SENT>
<SENT sid="8" pm="."><plain>Group 4 and Group 5, compared with Group 1, showed a significant higher prevalence of abnormal values of TWA_tot [odds ratio (OR) 1.70 (P= 0.002), and 2.07 (P= 0.01), respectively] and TWA_prec [OR 1.51 (P= 0.02) and 2.37 (P= 0.003), respectively] at multivariable analysis </plain></SENT>
<SENT sid="9" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> patients EST-induced <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> did not influence TWA; in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> patients, <z:hpo ids='HP_0005162'>impaired left ventricular function</z:hpo> was associated with higher TWA values </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: In healthy people, TWA_tot and TWA_prec were ≤75 and ≤65 µV, respectively, in 95% of subjects </plain></SENT>
<SENT sid="11" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IHD</z:e> patients TWA values were higher compared with healthy individuals; a history of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> was independently associated with abnormal TWA values </plain></SENT>
</text></document>